Foventa Therapeutics

Exonate

This biotechnology company develops non-invasive eye drops to treat patients with retinal vascular diseases such as diabetic retinopathy.

Tavo Biotherapeutics

The company develops topical and injectable treatments for patients with glaucoma and retinal diseases.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Vantage Biosciences

This clinical-stage biotechnology company develops oral therapies to treat diabetic retinopathy and other inflammatory conditions for patients with diabetic eye disease.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

Fovea

This company develops biopharmaceutical drugs to treat ocular diseases and retinal pathologies for patients with disabling eye conditions.

Breye Therapeutics

This biopharmaceutical company develops orally administered medicines for patients with retinal vascular diseases such as diabetic retinopathy and age-related macular degeneration.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.